Earlier this week, director of the Office of Science at the Food and Drug Administration’s Center for Tobacco Products (CTP), Matthew Holman, announced he is leaving his position at the agency for a job at tobacco giant Philip Morris International (PMI).
Filter revealed that in a letter addressed to his colleagues, Holman, who became CTP’s director only earlier this month, wrote that he would be departing “effective immediately,” revealing that the former OS head “has been on leave since before my tenure began at the Center” and saying that “he recused himself, consistent with agency ethics policies, from all CTP/FDA work while exploring career opportunities outside of government.”
An FDA spokesperson told Filter that the “FDA thanks Dr. Holman for his federal service and wishes him well. The work of the Center for Tobacco Products’ Office of Science is essential to our mission to protect Americans from tobacco-related disease and death. We are confident in the expertise and ability of our staff to continue this critical public health work while the Center for Tobacco Products conducts a nationwide search to identify the next Director for the Office of Science.”
Diane Caruana – VapingPost – 2022-07-28